Tissue Regenix Group

Tissue Regenix was established in May 2006 and is dedicated to the development of clinical solutions to address the chronic shortfalls in donor tissue availability in areas such as Vascular and Orthopaedic medicine. There is a well established clinical need for more donor tissue for many surgical procedures. Tissue Regenix will develop and commercialise acellular tissue repair products to meet this need, to ultimately benefit patients.
Type
Public
HQ
Swillington, GB
Founded
2006
Size (employees)
70 (est)+17%
Tissue Regenix Group was founded in 2006 and is headquartered in Swillington, GB

Tissue Regenix Group Office Locations

Tissue Regenix Group has offices in Swillington and San Antonio
Swillington, GB (HQ)
Astley Way
San Antonio, US
2611 North Loop 1604 W

Tissue Regenix Group Metrics

Tissue Regenix Group Financial Metrics

Revenue (2016)

£816 k

Revenue growth (2015-16), %

716%

Gross profit

£662 k

Gross profit margin (2016), %

81%

Market capitalization (28-Apr-2017)

£117.1 m

Closing share price (28-Apr-2017)

£0.2
Tissue Regenix Group's current market capitalization is £117.1 m.
Tissue Regenix Group's revenue was reported to be £816 k in FY, 2016 which is a 716% increase from the previous period.
FY, 2014FY, 2015FY, 2016

Revenue

£6 k£100 k£816 k

Revenue growth, %

1567%716%

Cost of goods sold

£32 k£154 k

Gross profit

£68 k£662 k

Gross profit Margin, %

68%81%

Operating expense total

£8.4 m£10.9 m

Tissue Regenix Group Market Value History

Tissue Regenix Group Online Presence

Tissue Regenix Group News

Tissue Regenix Group Company Life

You may also be interested in